An Eμ-BCL-2 transgene facilitates leukaemogenesis by ionizing radiation

Oncogene

Volumn 18, Issue 26, 1999, Pages 3870-3877

  Gibbons, Deena L ^a   MacDonald, Denise ^b   McCarthy, Keith P ^c   Cleary, Helen J ^b   Plumb, Mark ^b   Wright, Eric G ^b   Greaves, Mel F ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

Apoptosis; BCL 2; Irradiation; Leukaemogenesis

Indexed keywords

PROTEIN BCL 2;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL TYPE; CHROMOSOME ANALYSIS; CHROMOSOME DELETION 4; CLONE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HETEROZYGOSITY LOSS; IMMUNOGLOBULIN GENE; IMMUNOPHENOTYPING; IONIZING RADIATION; KARYOTYPE; LEUKEMIA CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRECURSOR; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; SOUTHERN BLOTTING; TRANSGENE; TRANSGENIC MOUSE; TRISOMY; X RAY;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; DNA REPAIR; GENES, BCL-2; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, RADIATION-INDUCED; MICE; MICE, TRANSGENIC; RECOMBINANT FUSION PROTEINS; TRANSGENES;

ANIMALIA; DROMAIUS NOVAEHOLLANDIAE; MURINAE; MUS MUSCULUS;

EID: 0033166430     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202721     Document Type: Article

References (40)

1. Alexander BJ, Rasko JEJ, Morahan G and Cook WD. (1995). Leukemia, 9, 2009-2015.
2. Boice JDJ and Inskip PD. (1996). In: Leukaemia. Henderson ES, Lister TA and Greaves MF (eds). WB Saunders Company, pp. 195-209.
3. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML and Wyllie AH. (1993). Nature, 362, 849-852.
4. Doll R and Wakeford R. (1997). Br. J. Radiol., 70, 130-139.
5. Domen J, Gandy KL and Weissman IL. (1998). Blood, 91, 2272-2282.
6. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS and Bradley A. (1992). Nature, 356, 215-221.
7. Fennelly J, Wright E and Plumb M. (1997). Leukemia, 11, 807-810.
8. Fisher DE. (1994). Cell, 78, 539-542.
9. Ford AM, Bennett CA, Healy LE, Navarro E, Spooncer E and Greaves MF. (1992). Proc. Natl. Acad. Sci. USA, 89, 3424-3428.
10. Ford AM, Watt SM, Furley AJW, Molgaard HV and Greaves MF. (1988). EMBO J., 7, 2393-2399.
11. Greaves MF. (1986). Science, 234, 697-704.
12. Greaves MF. (1997). Lancet, 349, 344-349.
13. Griffiths SD, Clarke AR, Healy LE, Ross G, Ford AM, Hooper ML, Wyllie AH and Greaves M. (1997). Oncogene, 14, 523-531.
14. Griffiths SD, Goodhead DT, Marsden SJ, Wright EG, Krajewski S, Reed JC, Korsmeyer SJ and Greaves M. (1994a). J. Exp. Med., 179, 1789-1797.
15. Griffiths SD, Marsden SJ, Wright EG, Greaves MF and Goodhead DT. (1994b). Int. J. Radiat. Biol., 66, 197-205.
16. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT and Weinberg RA. (1994). Curr. Biol., 4, 1-7.
17. Ji W, Qu G-Z, Ye P, Zhang X-Y, Halabi S and Ehrlich M. (1995). Cancer Res., 55, 2876-2882.
18. Kemp CJ, Wheldon T and Balmain A. (1994). Nature Genet., 8, 66-69.
19. Koyama M, Ishihara K, Karasuyama H, Cordell JL, Iwamoto A and Nakamura T. (1997). Int. J. Immunol., 9, 1767-1772.
20. Kuerbitz SJ, Plunkett BS, Walsh WV and Kastan MB. (1992). Proc. Natl. Acad. Sci. USA, 89, 7491-7495.
21. Liu Y, Hernandez AM, Shibata D and Cortopassi GA. (1994). Proc. Natl. Acad. Sci. USA, 91, 8910-8914.
22. Major IR and Mole RH. (1978). Nature, 272, 455-456.
23. Malumbres M, Perez de Castro I, Santos J, Melendez B, Mangues R, Serrano M, Pellicer A and Fernandez-Piqueras J. (1997). Oncogene, 14, 1361-1370.
24. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP and Korsmeyer SJ. (1989). Cell, 57, 79-88.
25. McDonnell TJ and Korsmeyer SJ. (1991). Nature, 349, 254-256.
26. Merino R, Ding L, Veis DJ, Korsmeyer SJ and Nuñez G. (1994). EMBO J., 13, 683-691.
27. Nishii K, Gibbons DL, Titley I, Papworth D, Goodhead DT and Greaves M. (1998). Cell Death Diff., 5, 77-86.
28. Nuñez G, Merino R, Grillot D and González-García M. (1994). Immunol. Today, 15, 582-588.
29. Osmond DG. (1993). Immunol. Today, 14, 34-37.
30. Paulovich AG, Toczyski DP and Hartwell LH. (1997). Cell, 88, 315-321.
31. Purdie CA, Harrison DJ, Peter A, Dobbie L, White S, Howie SEM, Salter DM, Bird CC, Wyllie AH, Hooper ML and Clarke AR. (1994). Oncogene, 9, 603-609.
32. Santos J, Perez de Castro I, Herranz M, Pellicer A and Fernandez-Piqueras J. (1996). Oncogene, 12, 669-676.
33. Strasser A, Elefanty AG, Harris AW and Cory S. (1996). EMBO J., 15, 3823-3834.
34. Strasser A, Harris AW, Bath ML and Cory S. (1990). Nature, 348, 331-333.
35. Strasser A, Harris AW and Cory S. (1993). Oncogene, 8, 1-9.
36. Upton AC, Wolff FF, Furth J and Kimball AW. (1958). Cancer Res., 18, 842-848.
37. Vaux DL, Cory S and Adams JM. (1988). Nature, 335, 440-442.
38. Wiener F, Ohno S, Spira J, Haran-Ghere N and Klein G. (1978). Nature, 275, 658-660.
39. Yang E and Korsmeyer SJ. (1996). Blood, 88, 386-401.
40. Zhuang S-M, Schippert A, Haugen-Strano A, Wiseman RW and Söderkvist. (1998). Oncogene, 16, 803-808.